NM_152443.3:c.-275+2688T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_152443.3(RDH12):​c.-275+2688T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 152,152 control chromosomes in the GnomAD database, including 1,473 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1473 hom., cov: 32)

Consequence

RDH12
NM_152443.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.284

Publications

1 publications found
Variant links:
Genes affected
RDH12 (HGNC:19977): (retinol dehydrogenase 12) The protein encoded by this gene is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. The encoded enzyme also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 13 and Retinitis Pigmentosa 53. [provided by RefSeq, Sep 2015]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.322 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RDH12NM_152443.3 linkc.-275+2688T>C intron_variant Intron 1 of 8 ENST00000551171.6 NP_689656.2 Q96NR8A0A0S2Z613
GPHNXM_047430879.1 linkc.1313-30572T>C intron_variant Intron 14 of 14 XP_047286835.1
RDH12XM_047430965.1 linkc.-309+2688T>C intron_variant Intron 1 of 8 XP_047286921.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RDH12ENST00000551171.6 linkc.-275+2688T>C intron_variant Intron 1 of 8 1 NM_152443.3 ENSP00000449079.1 Q96NR8

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19208
AN:
152034
Hom.:
1477
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0831
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.237
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.135
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.126
AC:
19206
AN:
152152
Hom.:
1473
Cov.:
32
AF XY:
0.134
AC XY:
9948
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0830
AC:
3445
AN:
41520
American (AMR)
AF:
0.156
AC:
2393
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
449
AN:
3464
East Asian (EAS)
AF:
0.237
AC:
1224
AN:
5160
South Asian (SAS)
AF:
0.335
AC:
1618
AN:
4824
European-Finnish (FIN)
AF:
0.135
AC:
1424
AN:
10582
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.121
AC:
8193
AN:
67990
Other (OTH)
AF:
0.135
AC:
286
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
826
1652
2477
3303
4129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.126
Hom.:
502
Bravo
AF:
0.123
Asia WGS
AF:
0.269
AC:
937
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.65
DANN
Benign
0.46
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12147616; hg19: chr14-68171340; API